Here are relevant reports on : point-of-care-pcr-market
-
PCR Technologies Market by Product (Instruments, Reagents & Consumables, Software), Application (Genotyping, Diagnostic Applications), Technique (Reverse Transcription PCR, qPCR), End-user (Hospital Labs, Diagnostic Labs) - Global Forecasts to 2030
The global PCR technologies market, valued at US$13.88 billion in 2023, stood at US$14.61 billion in 2024 and is projected to advance at a resilient CAGR of 7.0% from 2024 to 2030, culminating in a forecasted valuation of US$21.89 billion by the end of the period. The development of novel and innovative products and company initiatives, such as partnerships, product launches, approvals and acquisitions, have supported market growth.
- Published: January 2025
- Price: $ 4950
- TOC Available:
-
Digital PCR (dPCR) and Real-time PCR (qPCR) Market by Offering (Product (Reagents & Consumables, Instrument), Software, Services), Application (Clinical (infectious, Oncology), Research, Forensic, Environmental) - Global Forecast to 2029
The global Digital PCR and qPCR market, valued at US$9.4 billion in 2023, stood at US$10.0 billion in 2024 and is projected to advance at a resilient CAGR of 8.1% from 2024 to 2029, culminating in a forecasted valuation of US$14.8 billion by the end of the period. Growth in the digital PCR (dPCR) and real-time PCR (qPCR) market can be attributed to factors such as the rising incidence and prevalence of target infectious diseases and genetic disorders, continuous advancements in PCR technologies, the role of PCR in biomarker discovery, and increased use of dPCR and qPCR technologies for point of care (POC) diagnostics.
- Published: July 2024
- Price: $ 4950
- TOC Available:
-
Europe Point of Care Diagnostics Market by Product [Glucose, Infectious Disease (TB, HAI, STD), Pregnancy], Purchase Mode (Rx, OTC), Technology [Biochemistry, MDx (RT-PCR, INAAT)], Sample (Blood, Urine), End User (Home Care, Hospitals) - Forecast to 2031
The Europe point-of-care testing market, valued at USD4.14 billion in 2025, stood at USD4.45 billion in 2026 and is projected to advance at a resilient CAGR of 10.0% from 2026 to 2031, culminating in a forecasted valuation of USD7.17 billion by the end of the period. The Europe point-of-care diagnostics market is being fueled by a number of key drivers, including the increasing trend towards decentralized and community-based healthcare practices and the increasing demand for rapid clinical decision-making at or near the point of patient care.
- Published: March 2026
- Price: $ 4950
- TOC Available:
-
Latin America Point of Care Diagnostics Market by Product (Glucose, Infectious Disease [TB, HAI, STD], Pregnancy), Purchase Mode (Rx, OTC), Technology (Biochemistry, MDx [RT-PCR, INAAT]), Sample (Blood, Urine), End User (Home Care, Hospitals) - Forecast to 2031
The Latin America point-of-care diagnostics market, valued at US$0.75 billion in 2025, stood at US$0.79 billion in 2026 and is projected to advance at a resilient CAGR of 7.9% from 2026 to 2031, culminating in a forecasted valuation of US$1.15 billion by the end of the period. This growth is driven by the increasing demand for diagnostic solutions to address the rising burden of chronic and infectious diseases. Key factors contributing to this expansion include improvements in healthcare infrastructure, increased public and private investments in decentralized testing, and greater access to near-patient diagnostic technologies.
- Published: March 2026
- Price: $ 4950
- TOC Available:
-
Point of Care Diagnostics Market by Product (Glucose, Infectious Disease (TB, HAI, STD), Pregnancy), Purchase Mode (Rx, OTC), Technology (Biochemistry, MDx (RT-PCR, INAAT)), Sample (Blood, Urine), End User (Home Care, Hospitals) - Global Forecast to 2029
The global point of care diagnostics market, valued at US$14.26 billion in 2023, stood at US$15.05 billion in 2024 and is projected to advance at a resilient CAGR of 8.5% from 2024 to 2029, culminating in a forecasted valuation of US$22.63 billion by the end of the period. The growing prevalence of chronic diseases, such as diabetes has necessitated a need for routine monitoring with early and timely detection. Since these conditions need to be constantly monitored, the demand for quick, effective, and appropriate testing methods have expanded.
- Published: January 2025
- Price: $ 4950
- TOC Available:
-
US Point of Care Diagnostics Market by Product [Glucose, Infectious Disease (TB, HAI, STD), Pregnancy], Purchase Mode (Rx, OTC), Technology [Biochemistry, MDx (RT-PCR, INAAT)], Sample (Blood, Urine), End User (Home Care, Hospitals) - Forecast to 2031
The US Point of Care Diagnostics market, valued at US$6.4 billion in 2025, stood at US$6.8 billion in 2026 and is projected to advance at a resilient CAGR of 9.2% from 2026 to 2031, culminating in a forecasted valuation of US$10.6 billion by the end of the period. The primary factor driving the growth of the US point of care diagnostics market is the increasing demand for fast and reliable testing solutions to address the rising incidence of lifestyle and infectious diseases.
- Published: March 2026
- Price: $ 4950
- TOC Available:
-
Natural Personal Care Ingredients Market by Type (Emollients, Surfactnats, Rheology Modifiers, Preservatives, Active Ingredients), Application (Skin Care, Hair Care, Make-up, Oral Care), and Region - Global Forecast to 2028
The natural personal care ingredients market is expected to grow from USD 5.3 billion in 2022 to USD 7.9 billion by 2028, at a CAGR of 8.3% during the forecast period. The key players profiled in the report include BASF SE (Germany), Croda International Plc (UK), Ashland Inc. (US), The Lubrizol Corporation (US), Evonik Industries AG (Germany), Dow Inc. (US), Symrise AG (Germany), and others.
- Published: February 2024
- Price: $ 4950
- TOC Available:
-
Personal Care Ingredients Market by Ingredient Type (Emollients, Surfactants, Rheology Modifiers, Emulsifiers, Conditioning Polymers), Application (Skin Care, Hair Care, Oral Care, Makeup), and Region - Global Forecast to 2030
The personal care ingredients market size was USD 13.17 billion in 2024 and is projected to reach USD 17.00 billion by 2030, at a CAGR of 4.40%, between 2025 and 2030. The key market players profiled in the report include as BASF SE (Germany), Dow Inc. (US), Syensqo SA/NV (Belgium), Clariant AG (Switzerland), Ashland Inc. (US), ADEKA Corporation (Japan), The Lubrizol Corporation (US), Evonik Industries AG (Germany), Nouryon (Netherlands), and Croda International Plc (US).
- Published: July 2025
- Price: $ 4950
- TOC Available:
-
Transcutaneous Monitors Market by Type (Adult Wound Healing, Neonatal Care), Application (Sleep Diagnostics, Respiratory Care, Plastic surgery) & End User (Hospitals, Speciality Clinic, Neonatal Intensive Care, Diagnostic Center) - Global Forecast to 2023
The global transcutaneous monitors market is expected to reach USD 206.9 million by 2023 from USD 154.6 million in 2018, growing at a CAGR of 6.0%. Increasing demand for non-invasive monitoring; rising risk of respiratory diseases; increasing healthcare expenditure in developing economies such as India, China, Brazil; and technological advancement leading to more accuracy are some of the major factors driving the growth of the global transcutaneous monitors market. These driving factors consequence to the rapid adoption of these new devices, thus propelling the market growth.
- Published: April 2026
- Price: $ 4950
- TOC Available:
-
Digital Stethoscopes Market by Design Type (Tube-based, Tubeless), Connectivity (Wireless, Wired), Application (Cardiology, Pulmonary), End User (Hospitals, Urgent Care Centers, Ambulatory Care Centers, Home Care), and Region - Global Forecast to 2032
The global digital stethoscopes market, valued at US$467.7 million in 2024, stood at US$491.7 million in 2025 and is projected to advance at a resilient CAGR of 5.5% from 2025 to 2032, culminating in a forecasted valuation of US$717.3 million by the end of the period. The rising prevalence of chronic diseases, such as cardiovascular and respiratory conditions, combined with the introduction and approval of advanced digital stethoscopes, is driving significant market growth.
- Published: June 2025
- Price: $ 4950
- TOC Available:
Records 11 to 20 of 50
